Wellington Management Group LLP Travere Therapeutics, Inc. Transaction History

Wellington Management Group LLP

  • $557 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$5.26 - $8.28 $89,882 - $141,488
17,088 Added 30.75%
72,658 $597,000
Q1 2024

May 15, 2024
BUY
$7.18 - $9.82 $398,992 - $545,697
55,570 New
55,570 $428,000
Q4 2023

Feb 12, 2024
BUY
$5.44 - $9.5 $772,447 - $1.35 Million
141,994 New
141,994 $1.28 Million

Others Institutions Holding TVTX

# of Institutions
192
Shares Held
84.5M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.12B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email